Revenue Cycle Insider

Are you accurately capturing thyroid disorders from etiology to associated conditions?

Accurate coding of thyroid disorders presents an often underestimated challenge. Hypothyroidism and hyperthyroidism are common conditions with broad clinical presentations and nuanced ICD-10-CM coding requirements.

In primary care settings, clinicians will typically evaluate a patient’s symptoms and, if necessary, initiate treatment and coordinate follow-up care. Coders must then use the documentation to translate this process into precise codes and know when to ask for additional clarification.

Common pitfalls include failing to link thyroid disorders to their underlying causes and omitting relevant secondary codes for medication use or postprocedural status. Read on to learn how to reduce these errors by aligning documentation to ICD-10-CM requirements.

Hypothyroidism: Capture Etiology and Avoid Default Coding

Hypothyroidism reflects insufficient thyroid hormone production, but coders should not treat it as a one-size-fits-all diagnosis. The E03.- (Other hypothyroidism) range of the 10th edition of the ICD-10-CM code set includes specific codes that depend on etiology.

Avoid defaulting to E03.9 (Hypothyroidism, unspecified) when documentation supports a more specific code. Providers frequently diagnose autoimmune hypothyroidism, commonly referred to as Hashimoto’s thyroiditis. When documentation identifies this condition, assign E06.3 (Autoimmune thyroiditis) rather than a code from the E03.- range. If the provider documents both autoimmune thyroiditis and hypothyroidism, report both codes.

Coders should also pay close attention to hypothyroidism caused by external factors. When medications or other exogenous substances cause the condition, E03.2 (Hypothyroidism due to medicaments and other exogenous substances) applies. For patients who develop hypothyroidism after thyroidectomy or radioactive iodine therapy, assign E89.0 (Postprocedural hypothyroidism) if the documentation supports a clear link between the condition and the procedure.

Subclinical hypothyroidism presents another documentation and coding challenge. Providers may document elevated thyroid-stimulating hormone (TSH) levels with normal thyroxine (T4) without explicitly diagnosing hypothyroidism. Because ICD-10-CM does not include a distinct code for subclinical hypothyroidism, coders must rely on the provider’s diagnostic statement.

If the provider clearly documents hypothyroidism, assign a code from the E03.- range; but if not, look to the documentation. Consider R94.6 (Abnormal results of thyroid function studies) if abnormal thyroid test results prompt the encounter, or Z13.29 (Encounter for screening for other suspected endocrine disorder) for routine screening encounters for patients who do not have preexisting symptoms or abnormal laboratory results.

If the provider documents symptoms but not a definitive diagnosis or abnormal test results, assign symptom codes. Examples include R53.83 (Other fatigue), R63.5 (Abnormal weight gain), R63.4 (Abnormal weight loss), R00.2 (Palpitations), and R68.89 (Other general symptoms and signs).

Identify Cause and Severity for Hyperthyroidism

Hyperthyroidism involves excess thyroid hormone production and falls under ICD-10-CM category E05.- (Thyrotoxicosis [hyperthyroidism]). As with hypothyroidism, avoid overuse of unspecified codes such as E05.90 (Thyrotoxicosis, unspecified, without thyrotoxic crisis or storm). Instead, review documentation carefully to identify the underlying cause and level of severity.

When documentation confirms that a patient has Graves’ disease, select a code from the E05.0- (Thyrotoxicosis with diffuse goiter) range. From there, select the correct code based on whether the patient does or does not have thyroid storm, a life-threatening condition.

Keep in mind that some medications can contribute to hyperthyroidism. For example, excessive thyroid hormone replacement can cause iatrogenic hyperthyroidism. In these cases, coders may need to assign additional codes to capture adverse drug effects and follow ICD-10-CM guidelines for sequencing. Report the appropriate code from the E05.- range to identify the thyrotoxicosis, followed by a code from T38.1X5- (Adverse effect of thyroid hormones and substitutes) with the correct 7^th character to indicate the encounter (initial, subsequent, or sequela). Coders should also confirm that documentation supports that the medication was taken as prescribed rather than poisoning or overdose, which would require different code selection and sequencing.

Query providers when necessary to avoid errors. For example, if a provider documents hypothyroidism and references a prior thyroidectomy, confirm whether the condition is postprocedural. Or, if documentation suggests Graves’ disease but does not explicitly state it, seek clarification to support more specific coding.

Consider Codes for Ongoing Management

Thyroid disorders often coexist with structural abnormalities such as nodules or goiter; report these conditions separately when providers address them during the same encounter. For example, if a provider documents hypothyroidism and also evaluates a thyroid nodule, assign a code from the E03.- range for the hypothyroidism and a code such as E04.1 (Nontoxic single thyroid nodule) or E04.2 (Nontoxic multinodular goiter). The E04.- set (Other nontoxic goiter) covers structural abnormalities, while E03.- and E05.- describe functional disorders.

Medication management also plays a central role in thyroid care, and providers frequently prescribe long-term thyroid hormone replacement. In these cases, use Z79.899 (Other long term [current] drug therapy) when documentation supports ongoing management.

When a patient presents for routine follow-up of a diagnosed thyroid condition, list that condition as the primary diagnosis. When the encounter focuses solely on screening or lab testing without evaluation or management, consider codes such as Z13.29 (Encounter for screening for other suspected endocrine disorder) or Z01.89 (Encounter for other specified special examinations).

Michelle Falci, BA, M Falci Communications LLC